Vaccine makers sign safety pledge in race for COVID-19 vaccine
NEW YORK — According to published reports, nine drug companies pledged Tuesday that they will not submit vaccine candidates for FDA review until their safety and efficacy is shown in large clinical trials. The move is intended to bolster public confidence amid the rush to make a COVID-19 vaccine widely available, and counter fears of
